Literature DB >> 15365687

Global cognitive level and antidepressant efficacy in post-stroke depression.

Gianfranco Spalletta, Carlo Caltagirone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15365687     DOI： 10.1007/s00213-004-1977-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  5 in total

1.  A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.

Authors:  George S Zubenko; Wendy N Zubenko; Susan McPherson; Eleanor Spoor; Deborah B Marin; Martin R Farlow; Glenn E Smith; Yonas E Geda; Jeffrey L Cummings; Ronald C Petersen; Trey Sunderland
Journal:  Am J Psychiatry       Date:  2003-05       Impact factor: 18.112

2.  Lateralization of dementia of depression in stroke patients.

Authors:  K Bolla-Wilson; R G Robinson; S E Starkstein; J Boston; T R Price
Journal:  Am J Psychiatry       Date:  1989-05       Impact factor: 18.112

3.  Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?

Authors:  Gianfranco Spalletta; Giovanni Guida; Carlo Caltagirone
Journal:  J Neurol       Date:  2003-04       Impact factor: 4.849

4.  Predictors of cognitive level and depression severity are different in patients with left and right hemispheric stroke within the first year of illness.

Authors:  Gianfranco Spalletta; Giovanni Guida; Domenico De Angelis; Carlo Caltagirone
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

5.  Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.

Authors:  Liborio Rampello; Santina Chiechio; Giovanni Nicoletti; Alessandro Alvano; Ignazio Vecchio; Rocco Raffaele; Mariano Malaguarnera
Journal:  Psychopharmacology (Berl)       Date:  2003-12-17       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.